Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer.
暂无分享,去创建一个
Cecilia Sahlgren | Jessica M Rosenholm | J. Rosenholm | M. Lindén | Alain Duchanoy | D. Toivola | C. Sahlgren | L. Bergman | Veronika Mamaeva | Sebastian Landor | V. Mamaeva | Mika Lindén | Diana M Toivola | Alain Duchanoy | S. Landor | L. T. Bate-Eya | E. Peuhu | Lina E Fortelius | Emilia Peuhu | Lotta Bergman | Laurel Tabe Bate-Eya | Veronika Mamaeva | Lotta Bergman | Diana M. Toivola
[1] Minhong Yan,et al. Chronic DLL4 blockade induces vascular neoplasms , 2010, Nature.
[2] S. Artavanis-Tsakonas,et al. Notch signaling: cell fate control and signal integration in development. , 1999, Science.
[3] Yiyu Dong,et al. Synthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancer. , 2010, Cancer research.
[4] U. Lendahl,et al. Notch signaling mediates hypoxia-induced tumor cell migration and invasion , 2008, Proceedings of the National Academy of Sciences.
[5] M. Ferrari. Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.
[6] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[7] P. Majumder,et al. Targeting the Notch1 and mTOR pathways in a mouse T-ALL model. , 2009, Blood.
[8] Chindo Hicks,et al. Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. , 2008, Cancer research.
[9] Juan L. Vivero-Escoto,et al. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.
[10] K. Yano,et al. Direct synthesis of monodispersed thiol-functionalized nanoporous silica spheres and their application to a colloidal crystal embedded with gold nanoparticles , 2007 .
[11] Rasmus Niemi,et al. Targeting of porous hybrid silica nanoparticles to cancer cells. , 2009, ACS nano.
[12] J. Eriksson,et al. Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors. , 2010, Small.
[13] Cecilia Sahlgren,et al. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges. , 2010, Nanoscale.
[14] L. Miele. Rational targeting of Notch signaling in breast cancer , 2008, Expert review of anticancer therapy.
[15] J. Eriksson,et al. Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems. , 2009, Nano letters.
[16] Hiroshi Maeda,et al. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. , 2010, Bioconjugate chemistry.
[17] Hans Clevers,et al. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells , 2005, Nature.
[18] J. Fraser Stoddart,et al. Mesostructured multifunctional nanoparticles for imaging and drug delivery , 2009 .
[19] J. Rosenholm,et al. Cancer-cell targeting and cell-specific delivery by mesoporous silica nanoparticles , 2010 .
[20] S. Bray. Notch signalling: a simple pathway becomes complex , 2006, Nature Reviews Molecular Cell Biology.
[21] Iannis Aifantis,et al. γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia , 2009, Nature Medicine.
[22] Minhong Yan,et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis , 2006, Nature.
[23] Thijs J. Hagenbeek,et al. Therapeutic antibody targeting of individual Notch receptors , 2010, Nature.
[24] Chin-Tu Chen,et al. Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. , 2010, Biomaterials.
[25] S. Artavanis-Tsakonas,et al. Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine , 2009, Proceedings of the National Academy of Sciences.
[26] Raymond E. Moellering,et al. Direct inhibition of the NOTCH transcription factor complex , 2009, Nature.
[27] U. Lendahl,et al. Cross-talk between Notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches (Cancer Research (July 1, 2008) 68 (5226-5235)) , 2008 .
[28] Patrick Maisonneuve,et al. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis , 2004, The Journal of cell biology.
[29] Raphael Kopan,et al. The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.
[30] T. Yeatman,et al. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model. , 2010, Cancer research.
[31] Colleen Delaney,et al. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution , 2010, Nature Medicine.
[32] Y. Hung,et al. Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells , 2009 .
[33] S. Artavanis-Tsakonas,et al. Notch signals control the fate of immature progenitor cells in the intestine , 2005, Nature.
[34] Huang-Hao Yang,et al. An efficient cell-targeting and intracellular controlled-release drug delivery system based on MSN-PEM-aptamer conjugates , 2009 .
[35] T. Golde,et al. Notch signaling in cancer. , 2006, Current molecular medicine.
[36] K. Raj,et al. The role of Notch in tumorigenesis: oncogene or tumour suppressor? , 2003, Nature Reviews Cancer.
[37] Michelle Bradbury,et al. Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. , 2009, Nano letters.
[38] Zongxi Li,et al. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. , 2010, Small.
[39] Monty Liong,et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. , 2008, ACS nano.
[40] T. Golde,et al. Rational targeting of Notch signaling in cancer , 2008, Oncogene.
[41] Daniel J. Hoeppner,et al. Notch signalling regulates stem cell numbers in vitro and in vivo , 2006, Nature.
[42] Jay S. Fine,et al. Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation* , 2004, Journal of Biological Chemistry.